Insider Stock Purchases: September 24, 2026
On September 24, 2026, insiders made notable stock purchases: CAPSOVISION ($CV) insider bought 878,735 shares for $5M; NAYAX ($NYAX) CEO bought 104,511 shares for $4.6M; UXIN ($UXIN) insider bought 104.9M shares for $996K; PROTHENA ($PRTA) insider bought 100,000 shares for $843K; BRADESCO ($BBD) executive bought 43,620 shares for $784K.
How this was made
The 30-second read
Why it matters
While insider buying is generally viewed positively, the modest size of each transaction relative to the companies' market capitalizations limits any immediate trading impact.
Market read
The insider transactions are routine and provide limited actionable insight for traders; they may be noted for sentiment but are unlikely to drive significant price moves.
What to watch
Potential upcoming corporate actions or financing needs not disclosed may be driving the purchases.
Background
The article aggregates recent Form 4 insider purchase filings for several companies, highlighting the largest transactions on Sept. 24, 2026.
Ticker impact
CEO Nechmad Yair bought 104,511 shares of NAYAX Ltd. for an estimated $4.6M on Sept. 24, 2026.
Limited short‑term impact; price may see slight uptick if market perceives confidence.
Insider buying is a positive signal, yet the amount is relatively small and typical for a micro‑cap.
William P. Scully purchased 100,000 shares of Prothena Corp. Public Ltd Co. for an estimated $843,460 on Sept. 18, 2026.
Minimal effect; may provide slight bullish bias.
The purchase is a standard insider transaction without material scale.
Executive Alexandre Panico bought 43,620 shares of Bank Bradesco for an estimated $784,287 on Sept. 18, 2026.
Likely negligible price movement; may be viewed positively by investors.
The amount is small relative to the bank’s market cap; typical insider activity.
Market effects
Insider buying across small‑cap tech and financial firms may hint at sector confidence but is not material.
Brazilian and Israeli market participants may note the insider activity, but broader impact is limited.
Low; these are isolated insider transactions without macro implications.
Counterpoint
Insider purchases could be routine portfolio rebalancing rather than a genuine confidence signal.
Key entities
- CompanyNAYAX Ltd.
Israeli fintech firm listed on Nasdaq under NYAX.
- CompanyProthena Corp. Public Ltd Co.
Biopharma company listed on Nasdaq under PRTA.
- CompanyBanco Bradesco S.A.
Brazilian bank with ADR ticker BBD on NYSE.
